Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Gene Modified Immune Cells in Patients With Advanced Melanoma (F5)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Jonsson Comprehensive Cancer Center
California Institute of Technology
University of Southern California
University of Connecticut
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Jonsson Comprehensive Cancer Center Identifier:
First received: May 1, 2009
Last updated: September 7, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):